Jianzhijia Pharmaceutical Chain Group Balance Sheet Health
Financial Health criteria checks 3/6
Jianzhijia Pharmaceutical Chain Group has a total shareholder equity of CN¥2.9B and total debt of CN¥2.8B, which brings its debt-to-equity ratio to 96.7%. Its total assets and total liabilities are CN¥10.1B and CN¥7.2B respectively. Jianzhijia Pharmaceutical Chain Group's EBIT is CN¥604.4M making its interest coverage ratio 5.3. It has cash and short-term investments of CN¥780.1M.
Key information
96.7%
Debt to equity ratio
CN¥2.80b
Debt
Interest coverage ratio | 5.3x |
Cash | CN¥780.14m |
Equity | CN¥2.90b |
Total liabilities | CN¥7.16b |
Total assets | CN¥10.06b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 605266's short term assets (CN¥4.0B) do not cover its short term liabilities (CN¥4.9B).
Long Term Liabilities: 605266's short term assets (CN¥4.0B) exceed its long term liabilities (CN¥2.3B).
Debt to Equity History and Analysis
Debt Level: 605266's net debt to equity ratio (69.8%) is considered high.
Reducing Debt: 605266's debt to equity ratio has increased from 18.3% to 96.7% over the past 5 years.
Debt Coverage: 605266's debt is well covered by operating cash flow (28.3%).
Interest Coverage: 605266's interest payments on its debt are well covered by EBIT (5.3x coverage).